These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7598296)

  • 1. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.
    Bergasa NV; Alling DW; Talbot TL; Swain MG; Yurdaydin C; Turner ML; Schmitt JM; Walker EC; Jones EA
    Ann Intern Med; 1995 Aug; 123(3):161-7. PubMed ID: 7598296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
    Bergasa NV; Talbot TL; Alling DW; Schmitt JM; Walker EC; Baker BL; Korenman JC; Park Y; Hoofnagle JH; Jones EA
    Gastroenterology; 1992 Feb; 102(2):544-9. PubMed ID: 1732125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
    Bergasa NV; Alling DW; Talbot TL; Wells MC; Jones EA
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):431-4. PubMed ID: 10459118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
    Jones EA; Neuberger J; Bergasa NV
    QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
    Bergasa NV; McGee M; Ginsburg IH; Engler D
    Hepatology; 2006 Nov; 44(5):1317-23. PubMed ID: 17058231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of ondansetron in the pruritus of cholestasis.
    O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.
    Firouzian A; Gholipour Baradari A; Alipour A; Emami Zeydi A; Zamani Kiasari A; Emadi SA; Kheradmand B; Hadadi K
    J Neurosurg Anesthesiol; 2018 Jan; 30(1):26-31. PubMed ID: 27673505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
    Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
    Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
    Jones EA; Dekker LR
    Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intravenous naloxone in severe pruritus of acute cholestasis.
    Joshi GG; Thakur BS; Sircar S; Namdeo A; Jain AK
    Indian J Gastroenterol; 2009; 28(5):180-2. PubMed ID: 20107967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.
    Terg R; Coronel E; Sordá J; Muñoz AE; Findor J
    J Hepatol; 2002 Dec; 37(6):717-22. PubMed ID: 12445410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pruritus of cholestasis is relieved by an opiate antagonist: is this pruritus a centrally mediated phenomenon?
    Heathcote J
    Hepatology; 1996 May; 23(5):1280-2. PubMed ID: 8621166
    [No Abstract]   [Full Text] [Related]  

  • 14. Ondansetron and pruritus in chronic liver disease: a controlled study.
    Jones EA; Molenaar HA; Oosting J
    Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naloxone admixture to prevent opioid-induced pruritus in children: a randomized controlled trial.
    West N; Ansermino JM; Carr RR; Leung K; Zhou G; Lauder GR
    Can J Anaesth; 2015 Aug; 62(8):891-900. PubMed ID: 25902891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
    Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
    Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
    Kumar N; Garg N; Bailey A
    J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399
    [No Abstract]   [Full Text] [Related]  

  • 18. Naloxone infusion and post-hysterectomy morphine consumption: a double-blind, placebo-controlled study.
    Movafegh A; Shoeibi G; Ansari M; Sadeghi M; Azimaraghi O; Aghajani Y
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1241-9. PubMed ID: 22946762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
    Pereira MP; Werner MU; Dahl JB
    Trials; 2015 Nov; 16():511. PubMed ID: 26554360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.